• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于0.05%丙酸氯倍他索和0.12%戊酸倍他米松泡沫治疗轻至中度瘢痕疙瘩性痤疮的开放标签研究。

An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis.

作者信息

Callender Valerie D, Young Cherie M, Haverstock Christina L, Carroll Christie L, Feldman Steven R

机构信息

Callender Skin & Laser Center, 12164 Central Ave, Suite 225, Mitchellville, MD 20721, USA.

出版信息

Cutis. 2005 Jun;75(6):317-21.

PMID:16047868
Abstract

Acne keloidalis (AK) is a disease affecting primarily African American men. Topical steroids are a widely accepted treatment of AK; however, no studies have been published investigating their effectiveness. The purpose of this open-label study was to assess the efficacy and tolerability of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of AK in 20 African American patients. These patients were treated for 8 to 12 weeks using a pulsed-dose regimen. We found topical clobetasol propionate foam to be effective in improving AK, and our patients found the foam vehicle to be cosmetically acceptable.

摘要

瘢痕疙瘩性痤疮(AK)是一种主要影响非裔美国男性的疾病。外用类固醇是一种被广泛接受的AK治疗方法;然而,尚未有研究发表来调查其有效性。这项开放标签研究的目的是评估0.05%丙酸氯倍他索和0.12%戊酸倍他米松泡沫剂治疗20名非裔美国患者AK的疗效和耐受性。这些患者采用脉冲给药方案治疗8至12周。我们发现外用丙酸氯倍他索泡沫剂对改善AK有效,并且我们的患者认为该泡沫剂型在美观上是可以接受的。

相似文献

1
An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis.一项关于0.05%丙酸氯倍他索和0.12%戊酸倍他米松泡沫治疗轻至中度瘢痕疙瘩性痤疮的开放标签研究。
Cutis. 2005 Jun;75(6):317-21.
2
Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.中重度头皮银屑病患者中,每日两次倍他米松二丙酸酯增强型洗剂与丙酸氯倍他索溶液的疗效及安全性比较
Clin Ther. 1995 May-Jun;17(3):390-401. doi: 10.1016/0149-2918(95)80104-9.
3
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.0.25%的丙缩羟强的松龙乳膏及其相应的赋形剂比0.1%的倍他米松-17-戊酸酯乳膏和0.05%的丙酸氯倍他索乳膏引起的皮肤萎缩更少。
Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477.
4
Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.0.05%丙酸氯倍他索洗发水:治疗中度至重度头皮银屑病患者的新选择。
J Drugs Dermatol. 2004 Jul-Aug;3(4):367-73.
5
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.一项关于0.05%丙酸氯倍他索泡沫剂治疗非头皮银屑病的随机、双盲、安慰剂对照研究。
Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x.
6
The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.0.05%丙酸氯倍他索泡沫剂治疗非头皮部位轻至中度斑块状银屑病的疗效和耐受性。
J Cutan Med Surg. 2003 May-Jun;7(3):185-92. doi: 10.1007/s10227-002-0114-5.
7
Fatal iatrogenic Cushing's syndrome.致命性医源性库欣综合征
Lancet. 1979 Jan 27;1(8109):207. doi: 10.1016/s0140-6736(79)90597-x.
8
Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice.0.05%丙酸氯倍他索洗剂治疗头皮银屑病:一项日常临床实践研究。
J Eur Acad Dermatol Venereol. 2010 Apr;24(4):439-44. doi: 10.1111/j.1468-3083.2009.03436.x. Epub 2009 Oct 21.
9
Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.丙酸氯倍他索洗剂治疗中度至重度斑块型银屑病。
Cutis. 2004 Sep;74(3):201-6.
10
A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.一项关于0.05%丙酸氯倍他索(特美肤)头皮涂抹治疗中度至重度头皮银屑病的双盲、赋形剂对照研究。
J Am Acad Dermatol. 1991 Mar;24(3):443-7. doi: 10.1016/0190-9622(91)70069-e.

引用本文的文献

1
Treatment of acne keloidalis nuchae and dissecting cellulitis of the scalp with diclofenac sodium gel: a case series.双氯芬酸钠凝胶治疗瘢痕疙瘩性痤疮和头皮穿掘性蜂窝织炎:病例系列
JAAD Case Rep. 2023 Sep 27;42:113-116. doi: 10.1016/j.jdcr.2023.09.008. eCollection 2023 Dec.
2
Current and emerging treatment strategies for hair loss in women of color.针对有色人种女性脱发的当前及新兴治疗策略。
Int J Womens Dermatol. 2019 Jan 23;5(1):37-45. doi: 10.1016/j.ijwd.2018.10.021. eCollection 2019 Feb.
3
Combined effects of long-pulsed neodymium-yttrium-aluminum-garnet laser, diprospan and 5-fluorouracil in the treatment of keloid scars.
长脉冲钕钇铝石榴石激光、得宝松和5-氟尿嘧啶联合治疗瘢痕疙瘩的效果
Exp Ther Med. 2017 Jun;13(6):3607-3612. doi: 10.3892/etm.2017.4438. Epub 2017 May 8.
4
Acne keloidalis nuchae: prevalence, impact, and management challenges.瘢痕疙瘩性痤疮:患病率、影响及管理挑战。
Clin Cosmet Investig Dermatol. 2016 Dec 14;9:483-489. doi: 10.2147/CCID.S99225. eCollection 2016.
5
Electrosurgical excision of acne keloidalis nuchae with secondary intention healing.电外科切除项部瘢痕疙瘩性痤疮并行二期愈合。
J Clin Aesthet Dermatol. 2011 Jan;4(1):36-9.